Stay updated on Sitravatinib Combo in Clear-Cell RCC Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib Combo in Clear-Cell RCC Clinical Trial page.

Latest updates to the Sitravatinib Combo in Clear-Cell RCC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedUpdated the page to v3.2.0 and added a government-operating-status notice with links; removed the previous v3.1.0 reference.SummaryDifference5%
- Check18 days agoChange DetectedTerm naming updated from 'Clear cell renal carcinoma' to 'Clear cell carcinoma of kidney' with a version bump to v3.1.0.SummaryDifference0.4%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedVersion updated to v3.0.2; old tag v3.0.1 and the Back to Top element were removed. No substantive changes to core content, pricing, stock, or time slots.SummaryDifference0.3%
- Check39 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.3%
- Check47 days agoChange DetectedThe web page has been updated to include a new facility name and location, along with a list of relevant publications from PubMed related to clear cell renal carcinoma and sitravatinib. Notably, several terms related to antineoplastic agents and immune checkpoint inhibitors have been removed.SummaryDifference13%
- Check61 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Sitravatinib Combo in Clear-Cell RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib Combo in Clear-Cell RCC Clinical Trial page.